scispace - formally typeset
M

Michele Malaguarnera

Researcher at University of Catania

Publications -  127
Citations -  4645

Michele Malaguarnera is an academic researcher from University of Catania. The author has contributed to research in topics: Cancer & Hepatitis C. The author has an hindex of 31, co-authored 123 publications receiving 3846 citations. Previous affiliations of Michele Malaguarnera include University of Valencia.

Papers
More filters
Journal ArticleDOI

Vitamin D3: a helpful immuno-modulator

TL;DR: This review reports the new developments with specific reference to the metabolic and signalling mechanisms associated with the complex immune‐regulatory effects of vitamin D3 on immune cells.
Journal ArticleDOI

Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis

TL;DR: Bifidobacterium longum with Fos and lifestyle modification, when compared to lifestyle modification alone, significantly reduces TNF-α, CRP, serum AST levels, HOMA-IR, serum endotoxin, steatosis, and the NASH activity index.
Journal ArticleDOI

Omega-3 fatty acids and depression: Scientific evidence and biological mechanisms

TL;DR: Tertiary prevention with omega-3 PUFA supplement in depressed patients has reached greater effectiveness during the last recent years, although definitive statements on their use in depression therapy cannot be yet freely asserted.
Journal ArticleDOI

L-carnitine supplementation to diet: a new tool in treatment of nonalcoholic steatohepatitis--a randomized and controlled clinical trial.

TL;DR: L-carnitine supplementation to diet is useful for reducing TNF-α and CRP, and for improving liver function, glucose plasma level, lipid profile, HOMA-IR, and histological manifestations of NASH.
Journal ArticleDOI

Potential role of probiotics on colorectal cancer prevention

TL;DR: Several mechanisms could explain the preventive action of probiotics against colorectal cancer onset: alteration of the intestinal microflora; inactivation of cancerogenic compounds; competition with putrefactive and pathogenic microbiota; improvement of the host’s immune response; and inhibition of tyrosine kinase signaling pathways.